GJ103
CAS No. 1459687-89-8
GJ103( —— )
Catalog No. M18035 CAS No. 1459687-89-8
GJ103 sodium salt is an active analog of the read-through compound GJ072.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 71 | In Stock |
|
| 10MG | 119 | In Stock |
|
| 25MG | 235 | In Stock |
|
| 50MG | 285 | In Stock |
|
| 100MG | 348 | In Stock |
|
| 200MG | 425 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGJ103
-
NoteResearch use only, not for human use.
-
Brief DescriptionGJ103 sodium salt is an active analog of the read-through compound GJ072.
-
DescriptionGJ103 sodium salt is an active analog of the read-through compound GJ072. Some GJ072 analogs (e.g., GJ103, GJ106, GJ109, and GJ111) consistently demonstrates their activities in all three PTCs by both FCATMpSer1981 and IRIF assays. GJ103 have similar read-through activity as RTC13 or RTC14, but are more tolerable than RTC13 and RTC14 to A-T cells.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number1459687-89-8
-
Formula Weight342.37
-
Molecular FormulaC16H14N4O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESc1(n(c(nn1)SCC(=O)O)c1cc(ccc1)OC)c1ncccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Du L, et al. Mol Ther. 2013 Sep;21(9):1653-60.
molnova catalog
related products
-
IMSs inhibitor S12 P...
IMSs inhibitor S12 Perchlorate has antifibrotic and anticancer properties.
-
Dynamin inhibitory p...
Control peptide version of dynamin inhibitory peptide, myristoylated, an inhibitor of the GTPase dynamin that competitively blocks binding of dynamin to amphiphysin, preventing endocytosis. In contrast to dynamin inhibitory peptide, has no significant effect on GABAA receptor-mediated miniature IPSPs.
-
ART-CHEM-BB B025267
ART-CHEM-BB B025267 is the upregulator of utrophin production with EC50 of 1.8 μM and can be used in research on the treatment of Duchenne muscular dystrophy.
Cart
sales@molnova.com